290 related articles for article (PubMed ID: 25325260)
1. Fatal thrombotic thrombocytopenic purpura in a psoriasis patient treated with ustekinumab and methotrexate.
Philippe L; Badie J; Faller JP; Krattinger É; Deconinck E; Aubin F
Acta Derm Venereol; 2015 Apr; 95(4):495-6. PubMed ID: 25325260
[No Abstract] [Full Text] [Related]
2. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
[No Abstract] [Full Text] [Related]
3. Atopic dermatitis exacerbated with ustekinumab in a psoriatic patient with childhood history of atopy.
Lis-Święty A; Skrzypek-Salamon A; Arasiewicz H; Brzezińska-Wcisło L
Allergol Int; 2015 Oct; 64(4):382-3. PubMed ID: 26433537
[No Abstract] [Full Text] [Related]
4. Gastric mucosa-associated lymphoid tissue lymphoma in a patient with severe psoriasis receiving ustekinumab.
González-Ramos J; Alonso-Pacheco ML; Mayor-Ibarguren A; Herranz-Pinto P
Actas Dermosifiliogr; 2015 May; 106(4):326-7. PubMed ID: 25529464
[No Abstract] [Full Text] [Related]
5. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
Onsun N; Yalcin B; Sallahoglu K; Rezvani A
Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
[No Abstract] [Full Text] [Related]
6. Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy.
Fujita Y; Shinkuma S; Nomura T; Shimizu H
Eur J Dermatol; 2016 Apr; 26(2):187-8. PubMed ID: 26643260
[No Abstract] [Full Text] [Related]
7. Ustekinumab treatment in patients with psoriasis undergoing hemodialysis.
Umezawa Y; Hayashi M; Kikuchi S; Fukuchi O; Yanaba K; Ito T; Asahina A; Saeki H; Nakagawa H
J Dermatol; 2015 Jul; 42(7):731-4. PubMed ID: 25959602
[TBL] [Abstract][Full Text] [Related]
8. Psoriasis vulgaris complicated by eosinophilic pneumonia during ustekinumab treatment.
Yashiro M; Maejima H; Taniguchi T; Katsuoka K; Kimura M; Wada M
Eur J Dermatol; 2013; 23(3):396-7. PubMed ID: 23728153
[No Abstract] [Full Text] [Related]
9. Safety of ustekinumab in severe psoriasis with chronic hepatitis B.
Raymundo AR; Facin AP; Silva de Castro CC; Faria AR
Indian J Dermatol Venereol Leprol; 2016; 82(3):326-8. PubMed ID: 27088944
[No Abstract] [Full Text] [Related]
10. Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients.
Jones BB; Millsop JW; Walsh JA; Krueger GG; Callis Duffin K
Br J Dermatol; 2015 Jul; 173(1):272-4. PubMed ID: 25557081
[No Abstract] [Full Text] [Related]
11. Intracranial hypertension syndrome in a patient with psoriasis receiving ustekinumab.
Reyes Bueno JA; Reyes Garrido V; León A; Bustamante R
Neurologia (Engl Ed); 2019 May; 34(4):281-282. PubMed ID: 28712842
[No Abstract] [Full Text] [Related]
12. Interstitial pneumonia in two patients with psoriasis during ustekinumab treatment.
Kikuchi S; Umezawa Y; Hayashi M; Yanaba K; Fukuchi O; Ito T; Asahina A; Saeki H; Nakagawa H
J Dermatol; 2016 Jun; 43(6):712-3. PubMed ID: 26703791
[No Abstract] [Full Text] [Related]
13. Bullous pemphigoid during ustekinumab therapy in a psoriatic patient.
Onsun N; Sallahoglu K; Dizman D; Su Ö; Tosuner Z
Eur J Dermatol; 2017 Feb; 27(1):81-82. PubMed ID: 27777186
[No Abstract] [Full Text] [Related]
14. Thrombotic thrombocytopenic purpura or immune thrombocytopenia in a sickle cell/β+-thalassemia patient: a rare and challenging condition.
Vlachaki E; Agapidou A; Neokleous N; Adamidou D; Vetsiou E; Boura P
Transfus Apher Sci; 2014 Oct; 51(2):175-7. PubMed ID: 25266987
[TBL] [Abstract][Full Text] [Related]
15. Multiple Clustered Dermatofibromas Following Ustekinumab Treatment for
Ruiz-Villaverde R; Díaz-Martinez MA; Sánchez-Cano D
Sultan Qaboos Univ Med J; 2017 Aug; 17(3):e375-e377. PubMed ID: 29062570
[No Abstract] [Full Text] [Related]
16. [Ustekinumab-induced eosinophilic pneumonia during the course of ustekinumab therapy for plaque psoriasis].
Amy de la Bretèque M; Appere-De Vecchi C; Zeboulon C; Zaien I; Sigal ML; Mahé E
Ann Dermatol Venereol; 2015 Mar; 142(3):193-6. PubMed ID: 25624139
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous protothecosis in a patient on ustekinumab for psoriasis.
Jenkinson H; Thelin L; McAndrew R; Jones KM; Talbott LB; Diven D
Int J Dermatol; 2018 Oct; 57(10):1246-1248. PubMed ID: 29603193
[No Abstract] [Full Text] [Related]
18. Liver Injury in Psoriasis Patients Receiving Ustekinumab: A Retrospective Study of 44 Patients Treated in the Clinical Practice Setting.
Llamas-Velasco M; Concha-Garzón MJ; García-Diez A; Daudén E
Actas Dermosifiliogr; 2015; 106(6):470-6. PubMed ID: 25912374
[TBL] [Abstract][Full Text] [Related]
19. Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center.
Heinecke GM; Luber AJ; Levitt JO; Lebwohl MG
J Drugs Dermatol; 2013 Oct; 12(10):1098-102. PubMed ID: 24085044
[TBL] [Abstract][Full Text] [Related]
20. Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?
Gkini MA; Bewley AP
Dermatol Ther; 2018 Nov; 31(6):e12742. PubMed ID: 30221819
[No Abstract] [Full Text] [Related]
[Next] [New Search]
